4.6 Article

Polyamines Affect Histamine Synthesis During Early Stages of IL-3-Induced Bone Marrow Cell Differentiation

期刊

JOURNAL OF CELLULAR BIOCHEMISTRY
卷 108, 期 1, 页码 261-271

出版社

WILEY
DOI: 10.1002/jcb.22246

关键词

BIOGENIC AMINES; INFLAMMATORY MEDIATORS; MAST CELLS; METABOLIC INTERPLAY

资金

  1. Ministerio de Ciencia y Tecnologia (Spain) [SAF-2008-02522]
  2. Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Raras (CIBER-ER)
  3. Junta de Andalucia (Spain) [BID 267]

向作者/读者索取更多资源

Mast cells synthesize and store histamine, a key immunomodulatory mediator. Polyamines are essential for every living cell. Previously, we detected an antagonistic relationship between the metabolisms of these amines in established mast cell and basophilic cell lines. Here, we used the IL-3-driven mouse bone marrow-derived mast cell (BMMC) culture system to further investigate this antagonism in a mast cell model of deeper physiological significance. Polyamines and histamine levels followed opposite profiles along the bone marrow cell cultures leading to BMMCs. alpha-Difluoromethylornithine (DFMO)-induced polyamine depletion resulted in an upregulation of histidine decarboxylase (HDC, the histamine-synthesizing enzyme) expression and activity, accompanied by increased histamine levels, specifically during early stages of these cell cultures, where an active histamine synthesis process occurs. In contrast, DFMO did not induce any effect in either HDC activity or histamine levels of differentiated BMMCs or C57.1 mast cells, that exhibit a nearly inactive histamine synthesis rate. Sequence-specific DNA methylation analysis revealed that the DFM0-induced HDC mRNA upregulation observed in early bone marrow cell cultures is not attributable to a demethylation of the gene promoter caused by the pharmacological polyamine depletion. Taken together, the results support an inverse relationship between histamine and polyamine metabolisms during the bone marrow cell cultures leading to BMMCs and, moreover, suggest that the regulation of the histamine synthesis occurring during the early stages of these cultures depends on the concentrations of polyamines. J. Cell. Biochem. 108: 261-271, 2009. (C) 2009 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

Cancer epigenetics in clinical practice

Veronica Davalos, Manel Esteller

Summary: Cancer development is caused by changes in the structure and function of the genome. Epigenetic alterations regulate gene expression programs that promote tumorigenesis and can be used as useful tools in clinical decision making. Unlike genetic changes, epigenetic modifications can be reversed, making them an attractive target for drug development.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Review Oncology

International consensus on the initial diagnostic workup of cancer of unknown primary

Iris van der Strate, Fatemeh Kazemzadeh, Iris D. Nagtegaal, Debbie Robbrecht, Agnes van de Wouw, Catarina S. Padilla, Saskia Duijts, Manel Esteller, F. Anthony Greco, Nicholas Pavlidis, Amir Qaseem, Petur Snaebjornsson, Sophie Veldhuijzen van Zanten, Caroline Loef

Summary: The study proposes a multi-layer classification for the diagnostic workup of CUP using the Delphi method. The recommended initial diagnostic includes history and physical examination, full blood count, serum marker analysis, biopsy of accessible lesion, CT scan, and immunohistochemical testing. Consensus was also reached on the need for an ideal diagnostic lead time for CUP patients.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Maternal obesity and gestational diabetes reprogram the methylome of offspring beyond birth by inducing epigenetic signatures in metabolic and developmental pathways

Juan Jose Alba-Linares, Raul F. Perez, Juan Ramon Tejedor, David Bastante-Rodriguez, Francisco Ponce, Nuria Garcia Carbonell, Rafael Gomez Zafra, Agustin F. Fernandez, Mario F. Fraga, Empar Lurbe

Summary: Maternal obesity or gestational diabetes mellitus are significant risk factors for cardiometabolic diseases in children. A study on the DNA methylation landscape of children born to mothers with obesity and gestational diabetes found abundant methylation changes during the first 6 months of life, associated with genes and pathways involved in fatty acid metabolism, developmental processes, and mitochondrial bioenergetics. The study also revealed an interaction between developmental methylation changes and maternal metabolic alterations.

CARDIOVASCULAR DIABETOLOGY (2023)

Article Biochemistry & Molecular Biology

Validation of the new EPIC DNA methylation microarray (900K EPIC v2) for high-throughput profiling of the human DNA methylome

Aleix Noguera-Castells, Carlos A. Garcia-Prieto, Damiana Alvarez-Errico, Manel Esteller

Summary: DNA methylation, a well-studied epigenetic mark, plays a critical role in gene regulation and is altered in cancer and other diseases. The newly developed 900K EPIC v2 microarray provides significant improvements in coverage and includes additional probes for DNA cis-regulatory regions. Validation studies demonstrate the reproducibility and versatility of this updated tool for studying the DNA methylome.

EPIGENETICS (2023)

Article Gastroenterology & Hepatology

The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

Naroa Goikoetxea-Usandizaga, Miren Bravo, Leire Egia-Mendikute, Leticia Abecia, Marina Serrano-Macia, Rocio G. Urdinguio, Marc Clos-Garcia, Ruben Rodriguez-Agudo, Raquel Araujo-Legido, Lucia Lopez-Bermudo, Teresa C. Delgado, Sofia Lachiondo-Ortega, Irene Gonzalez-Recio, Claudia Gil-Pitarch, Ainize Pena-Cearra, Jorge Simon, Raquel Benede-Ubieto, Silvia Arino, Jose M. Herranz, Mikel Azkargorta, Julio Salazar-Bermeo, Nuria Marti, Marta Varela-Rey, Juan M. Falcon-Perez, Oscar Lorenzo, Ruben Nogueiras, Felix Elortza, Yulia A. Nevzorova, Francisco J. Cubero, Domingo Saura, Luis Alfonso Martinez-Cruz, Guadalupe Sabio, Asis Palazon, Pau Sancho-Bru, Natalia Elguezabal, Mario F. Fraga, Matias A. Avila, Ramon Bataller, Jose J. G. Marin, Franz Martin, Maria Luz Martinez-Chantar

Summary: Alcohol-associated liver disease (ALD), accounting for 70% of liver-related deaths in Europe, has no effective approved therapies. However, targeting methylation-controlled J protein (MCJ) may help in recovering mitochondrial fitness without collateral oxidative damage. Liver-specific MCJ silencing can prevent major ALD hallmarks, such as mitochondrial dysfunction, steatosis, inflammation, and oxidative stress, improving lipid metabolism and liver injury.

HEPATOLOGY (2023)

Article Biochemistry & Molecular Biology

Unexpected thermodynamic signature for the interaction of hydroxymethylated DNA with MeCP2

David Ortega-Alarcon, Rafael Claveria-Gimeno, Sonia Vega, Olga C. Jorge-Torres, Manel Esteller, Olga Abian, Adrian Velazquez-Campoy

Summary: Hydroxymethylated cytosine (5hmC) is a stable DNA epigenetic mark that interacts with MeCP2 in a distinct mode with a specific thermodynamic signature. Mutations associated with Rett syndrome alter the interaction between MeCP2 and dsDNA in a cytosine modification-specific manner, which may be correlated with disease onset time and clinical severity score.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2023)

Article Biochemistry & Molecular Biology

Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease

Miriam Gene, Miriam Cuatrecasas, Irene Amat, Jesus Alberto Veiga, Maria Jesus Fernandez Acenero, Victoria Fuste Chimisana, Jordi Tarragona, Ismael Jurado, Rebeca Fernandez-Victoria, Carolina Martinez Ciarpaglini, Cristina Alenda Gonzalez, Carlos Zac, Pilar Ortega de la Obra, Maria Teresa Fernandez-Figueras, Manel Esteller, Eva Musulen

Summary: Colitis-associated colorectal carcinoma (CAC) in inflammatory bowel disease (IBD) is caused by p53 alterations and follows a chronic inflammation-dysplasia-cancer carcinogenesis pathway. Gastric metaplasia (GM) is described as the initial event of serrated colorectal cancer (CRC) in the colon mucosa under chronic stress. This study analyzed p53 alterations and microsatellite instability (MSI) to characterize CAC and investigate its relationship with GM. Results showed that p53 mutation pattern was present in more than half of the CAC cases, with stable (MSS) tumors being the most common and MUC5AC negative. Only six unstable (MSI-H) tumors had wild-type p53 pattern (p=0.010) and were MUC5AC positive (p=0.005). MUC5AC staining was more frequently observed in intestinal mucosa with inflammation or chronic changes than in CAC, particularly in those with wild-type p53 pattern and MSS.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Multidisciplinary Sciences

The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma

Lucia Morgado-Palacin, Jessie A. Brown, Thomas F. Martinez, Juana M. Garcia-Pedrero, Farhad Forouhar, S. Aidan Quinn, Clara Reglero, Joan Vaughan, Yasamin Hajy Heydary, Cynthia Donaldson, Sandra Rodriguez-Perales, Eva Allonca, Rocio Granda-Diaz, Agustin F. Fernandez, Mario F. Fraga, Arianna L. Kim, Jorge Santos-Juanes, David M. Owens, Juan P. Rodrigo, Alan Saghatelian, Adolfo A. Ferrando

Summary: The TINCR gene plays an important role in epithelium tissues, controlling human epidermal differentiation and wound healing. It has been found to have tumor suppressor properties in squamous cell carcinoma (SCC), being upregulated by UV-induced DNA damage in a TP53-dependent manner. TINCR expression inhibits the growth of SCC cells in vitro and in vivo, and deletion or mutation of the TINCR gene has been observed in SCC clinical samples. These findings highlight the significance of TINCR as a protein coding tumor suppressor gene lost in squamous cell carcinomas.

NATURE COMMUNICATIONS (2023)

Article Multidisciplinary Sciences

Circulating miRNA expression in long-standing type 1 diabetes mellitus

Paula Morales-Sanchez, Carmen Lambert, Jessica Ares-Blanco, Lorena Suarez-Gutierrez, Elsa Villa-Fernandez, Ana Victoria Garcia, Miguel Garcia-Villarino, Juan Ramon Tejedor, Mario F. Fraga, Edelmiro Menendez Torre, Pedro Pujante, Elias Delgado

Summary: This study aimed to analyze the circulating miRNA expression profile of patients with type 1 diabetes and no other associated pathology. The expression of hsa-miR-1-3p was found to be significantly increased in patients with type 1 diabetes and positively correlated with glycated haemoglobin levels. Changes in hsa-miR-1-3p were also found to directly affect genes involved in vascular development and cardiovascular pathologies. Circulating hsa-miR-1-3p, along with glycemic control, could be used as prognostic biomarkers in type 1 diabetes to prevent the development of vascular complications in these patients.

SCIENTIFIC REPORTS (2023)

Article Multidisciplinary Sciences

Nicotinamide N-methyltransferase (NNMT) regulates the glucocorticoid signaling pathway during the early phase of adipogenesis

Annalisa Roberti, Juan Ramon Tejedor, Irene Diaz-Moreno, Virginia Lopez, Pablo Santamarina-Ojeda, Raul F. Perez, Rocio G. Urdinguio, Carmen Concellon, Maria Luz Martinez-Chantar, Juan Luis Fernandez-Morera, Antonio Diaz-Quintana, Vicente del Amo, Agustin F. Fernandez, Mario F. Fraga

Summary: Obesity is associated with dysfunction of adipose tissue, and this study identifies the role of nicotinamide N-methyltransferase (NNMT) in the adipogenesis process. NNMT is transactivated by CCAAT/Enhancer Binding Protein beta (CEBPB) during the early phase of adipocyte differentiation. Knockout and inhibition of NNMT impair terminal adipogenesis, suggesting that NNMT is a key component during the early stages of adipogenesis and could be a potential therapeutic target for obesity.

SCIENTIFIC REPORTS (2023)

Review Oncology

Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics

Maxime Janin, Veronica Davalos, Manel Esteller

Summary: Most cancer-related deaths and illnesses can be attributed to metastasis. The role of epigenetic and epitranscriptomic changes in the origin and progression of cancer has been extensively demonstrated. These two-layer regulatory mechanisms, driven by DNA or RNA modifiers, are finely controlled in normal tissue but dysregulated in cancer. Understanding these mechanisms could have important clinical implications for prevention and management of advanced malignancies. Reversing these epi-alterations with small molecules or inhibitors against epi-modifiers could offer novel therapeutic alternatives.

CANCER AND METASTASIS REVIEWS (2023)

Letter Oncology

Response to Kang et al.

Carlos A. Garcia-Prieto, Veronica Davalos, Manel Esteller

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome

Lucia Salz, Alexander Seitz, Daniel Schaefer, Julia Franzen, Tatjana Holzer, Carlos A. Garcia-Prieto, Iris Buerger, Olaf Hardt, Manel Esteller, Wolfgang Wagner

Summary: CAR T cell expansion during culture leads to DNA hypermethylation, which downregulates the expression of genes relevant to T cell function. This hypermethylation signature can predict cell culture time and is associated with reduced long-term survival and therapeutic outcome in CAR T cell products.

LEUKEMIA (2023)

Article Oncology

Multi-omic integration of DNA methylation and gene expression data reveals molecular vulnerabilities in glioblastoma

Pablo Santamarina-Ojeda, Juan Ramon Tejedor, Raul F. Perez, Virginia Lopez, Annalisa Roberti, Cristina Mangas, Agustin F. Fernandez, Mario F. F. Fraga

Summary: Glioblastoma (GBM) is an aggressive and heterogeneous type of cancer, posing challenges in developing effective treatments. Incorporating molecular features into diagnosis has improved categorization of GBM subtypes, revealing subtype-specific vulnerabilities. By integrating gene expression and DNA methylation data, potential vulnerabilities in GBM patients were identified, implicating the AP-1, SMAD3, and RUNX1/RUNX2 pathways in tumor development. Inhibition of these pathways, with or without the chemotherapy agent temozolomide, led to impaired tumor growth, particularly in the aggressive, mesenchymal-like subtype. These findings have implications for personalized therapeutic approaches.

MOLECULAR ONCOLOGY (2023)

Article Cell Biology

DPPA3-HIF1a axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype

Estefania Cuesta-Borras, Candida Salvans, Oriol Arques, Irene Chicote, Lorena Ramirez, Laia Cabellos, Jordi Martinez-Quintanilla, Alex Mur-Espinosa, Alejandro Garcia-Alvarez, Jorge Hernando, Juan Ramon Tejedor, Oriol Mirallas, Elena Elez, Mario F. Fraga, Josep Tabernero, Paolo Nuciforo, Jaume Capdevila, Hector G. Palmer, Isabel Puig

Summary: Tumor relapse and chemoresistance are major challenges in cancer therapy. This study reveals that DPPA3 plays a crucial role in promoting slow-cycling and chemoresistant phenotype in colorectal cancer. The study also uncovers a feedback loop between DPPA3 and HIF1a that regulates cell-cycle progression and highlights the potential of downregulating HIF1a to restore chemosensitivity. Furthermore, DPPA3 overexpression is identified as a biomarker for chemotherapeutic resistance in CRC patients.

CELL REPORTS (2023)

暂无数据